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ABSTRACT 
 
Enteric diseases have a high economic impact on animal production, being the interstitial and intracellular fluids, the 
main sites of infection (biophase) of the pathogens responsible for these disorders. Fosfomycin is an antibiotic widely 
used for the treatment and prevention of swine infections caused by resistant bacteria. For most of the important 
pathogens in swine production, fosfomycin MIC90 has been established in 0.25-4 µg/mL. Calcium fosfomycin 
concentrations in swine intestinal cells were previously determined by in vitro and ex vivo studies, although, still now, 
there are no in vivo studies showing the exposure of minimum inhibitory concentrations of fosfomycin in the enteric 
infectious site. According to this background, the aim of this research was to determine in vivo calcium fosfomycin 
concentrations on swine intestinal cells. Four clinically healthy post-weaning piglets 4-5 weeks old were used. 
Animals were sacrificed after 15 days of calcium fosfomycin consumption in the drinking water (30 mg/kg).  After 
slaughtering, jejunum was removed. Intracellular concentrations of the antibiotic were analyzed by HPLC MS/MS and 
they ranged from 0.82 to 2.05 µg/mL. These concentrations exceed the MIC90 of intestinal pathogens such as E.coli 
(0.5 μg/mL), although they are lower than the MIC90 of Salmonella enterica (4 μg/mL).  
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INTRODUCTION 
 
In pig production, weaning is considered as a critical 
period for piglets. It is characterized by a decrease in food 
intake that leads to a status of undernutrition, affecting 
other aspects of animal physiology and metabolism 
(Dirkzwager et al., 2005). During this period animals are 
more susceptible to infectious diseases (Nabuurs et al., 
1993). In this regard, enteric diseases have a high 
economic impact on animal production, being the 
interstitial and intracellular fluids, the main sites of 
infection (biophase) of the pathogens responsible for these 
disorders (Dosen et al., 2007; Ross, 2006). It should be 
noted that most of the enteric diseases are caused by 
intracellular organisms, such as Salmonella sp. 
(facultative intracellular) and Lawsonia intracellularis 
(obligate intracellular) ( Pedersen et al., 2008; Pluske et 
al., 1996), although other microorganisms that are located 
at the extracellular level are also important, such as 
Escherichia coli, Brachyspira hyodisenteriae and 
Brachyspira pilosicoli. 
Different antibiotics have been used for decades to 
reduce pathogen infections in pigs, leading to irrational 
use. For this reason, many bacteria have become resistant 
to the most frequently used antimicrobials (Dirkzwager et 
al., 2005; Mathew et al., 1998; Rood et al., 1985). 
Fosfomycin (cis-1,2-epoxyphosphonic acid), an intensive 
production widely used drug (Serrano, 2002), is among 
the most recently used antimicrobials. It is a broad-
spectrum antibiotic, structurally unrelated to other classes 
of agents. Fosfomycin inhibits cell wall synthesis as it 
interferes with peptidoglycan production at an earlier 
stage than beta-lactams or glycopeptide antibiotics 
(Gobernado, 2003; Kahan et al., 1974; Lin, 1976; 
Popovic, 2010). It has a low molecular weight (138.059 
Da) and its chemical structure is similar to that of 
phosphoenolpyruvate. In animals, the fosfomycin-calcium 
salt formulation is used orally, whereas the more water- 
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soluble disodium salt is used intravenously and 
intramuscularly.  
The use of fosfomycin in animals and humans has 
been proposed because of its low toxicity and potential 
efficacy (Gallego et al., 1974). It is also widely used in 
animal production due to its rapid effect, good tolerance 
and lack of side effects (Aramayona et al., 1997; 
Caramiñana et al., 2004). It is indicated for the treatment 
of a variety of porcine bacterial pathogens (Haemophilus 
parasuis, Streptococcus suis, Pasteurella multocida, 
Bordetella bronchiseptica, Staphylococcus hyicus, E. coli 
and Salmonella enterica) associated with stress and/or 
several viral diseases (Martineau, 1997). For most of the 
important pathogens in swine production, fosfomycin 
minimum inhibitory concentration which kills the 90% of 
the microorganisms (MIC90) has been established in 0.25-4 
µg/mL (Fernández et al., 1995; Ibar et al., 2009; Sumano 
et al., 2007). In this regard, an aspect of importance is that 
fosfomycin exhibits a time dependent-killing, so it kills 
bacteria when its concentrations remain constantly above 
the MIC (Aliabadi and Lees, 1997; Toutain et al., 2002). 
Therefore, for an antibiotic to be effective against relevant 
pathogens, it is essential to reach concentrations higher 
than the MIC at the site of action (Nix et al., 1991; 
Schentag et al., 1991; Toutain et al., 2002). 
Another relevant point to consider is that antibiotics 
with high lipid solubility are able to penetrate cell 
membranes, however, fosfomycin is a hydrophilic drug 
and, therefore, transmembrane passive diffusion appears 
as a mechanism of lower cellular penetration (Hoger, 
1985). In this regard, Soraci et al. (2012) and Pérez et al. 
(2012a), have demonstrated that disodium fosfomycin 
penetrates into pulmonary epithelial lining fluid and in 
respiratory cells (HEP-2 cells), respectively, and reaches 
concentrations that exceed the MIC90 for the most 
important pathogens in swine respiratory infections. These 
findings show that disodium fosfomycin is an alternative 
for the treatment of intracellular respiratory infections in 
pigs. Disodium fosfomycin penetration has also been 
demonstrated in swine white blood cells at concentrations 
higher than the MIC90 (Pérez Gaudio et al., 2018a). In 
previous studies, we have determined calcium fosfomycin 
pharmacokinetics and bioavailability in post weaning 
piglets after oral administration of a 30 mg/kg dose. 
According to our studies, F% of calcium FOS is low (20). 
Therefore, considering the large quantity of drug that 
remains in the intestine and that fosfomycin is also a good 
antibiotic to treat pathogens at the extracellular level, 
calcium fosfomycin would be appropriate for the 
treatment of some enteric infections in pigs (Pérez et al., 
2012b). Previously, we have also studied the penetration 
of calcium fosfomycin into an in vitro model of intestinal 
cells (IPEC-J2 cells), where cultures were subjected to a 
concentration of 580 μg/ml (Pérez et al., 2013). On our 
work group we have also demonstrated ex vivo calcium 
fosfomycin penetration on swine intestinal explants (Pérez 
Gaudio et al., 2018b). Both in the IPEC-J2 cell assays and 
in the studies with intestinal explants, calcium fosfomycin 
reached intracellular concentrations higher than the MIC90 
for pathogens responsible for swine enteric diseases. 
Although we have determined, by in vitro and ex vivo 
studies, calcium fosfomycin concentrations in swine 
intestinal cells which exceed the MIC90 for enteric 
pathogens, still now, there are no in vivo studies showing 
that this antibiotic reaches adequate concentrations in the 
enteric biophase where the most important pathogens 
operate. According to this background, the aim of this 
work was to determine in vivo calcium fosfomycin 
concentrations on swine intestinal cells. 
 
MATERIALS AND METHODS 
 
Animals 
To carry out this study, four clinically healthy post-
weaning piglets 4-5 weeks old were used. Animals were 
weighed, identified and housed in pens in the weaning 
room, with free access to water and food. 
 
Antibiotic 
Calcium fosfomycin (98.9% of purity) was from 
Bedson Laboratory, Pilar, Buenos Aires, Argentina. For 
PO administration, calcium fosfomycin formulation (30 
mg/kg), was weighed and diluted in drinking water, taking 
into account a water consumption per animal of 1 L daily. 
 
Experimental design 
After 15 days of antibiotic consumption in the 
drinking water, pigs were sacrificed.  After slaughtering, 
small intestines (jejunum) were immediately removed and 
intestinal contents were washed and detached with 
physiological saline solution (PSS). Samples were 
transported to the Laboratory of Toxicology at 2-4°C. 
Jejunum samples were cut into fragments of 3 cm in 
length and then opened along the mesenteric border. 
Tissues were placed in 60-mm Petri dishes. To eliminate 
the mucus and the remaining intestinal contents, they were 
washed twice with PSS by shaking for 10 min. The 
mucosa was cut into circular pieces of 1.3 cm2, with a 
weight of 0.1 g (Nietfeld et al., 1991; Zhu et al., 1995). 
Samples were analyzed by HPLC-MS/MS, using our 
previously developed methodology as described in Pérez 
Gaudio et al. (2018b). 
 
RESULTS 
 
A total of 16 samples of intestinal mucosa (four per 
animal) were analyzed. The average intracellular 
concentration of fosfomycin in intestinal cells after 
consumption of the antibiotic in drinking water for 15 days 
(at a rate of 30 mg/kg of b.w.) was 1.35 μg/mL, with an SD 
of 0.37. Figure 1 shows the obtained concentrations for each 
sample. 
 
 
Fig. 1: Intracellular penetration of calcium fosfomycin in 
intestinal cells, after a 15-day continuous consumption of the 
antibiotic in drinking water. 
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DISCUSSION 
 
In vivo calcium fosfomycin concentrations 
(between 0.82 and 2.05 μg/mL) were significantly lower 
than in our previous in vitro studies on IPEC-J2 cells 
(P<0.005) (Pérez et al., 2013). Among the factors that 
influence these lower concentrations it should be 
considered the processes that the drug suffers in vivo in 
the animal as fosfomycin degradation by the acid pH of 
pigs’ stomach, the great adsorption of this drug to the food 
(Pérez et al., 2012b), and dilution with digestive fluids at 
intestinal level, not only with the volume of liquid present 
(0.62 L) (Ruckebusch et al., 1981), but also with 
secretions that are dumped into the duodenum from the 
gallbladder and pancreas. In addition, the intestinal 
epithelium is renewed every 2-3 days and in the in vivo 
study, there was a continuous entry of the drug with many 
cells exposed to a low concentration of the antibiotic.  
 
Conclusions 
Concentrations found in vivo exceed the MIC90 of 
intestinal pathogens such as E.coli (0.5 μg/mL), although 
they are lower than the MIC90 of Salmonella enterica (4 
μg/mL). Both pathogens are aerobic-anaerobic facultative, 
and most of their life cycle goes outside the cell. The 
MIC90 of fosfomycin for L. intracellularis, obligate 
intracellular pathogen, has yet not been determined. 
However, calcium fosfomycin penetration on intestinal 
explants infected with this pathogen has been confirmed 
(Pérez Gaudio et al., 2018b). 
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